Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00849121. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT01171898. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment
ClinicalTrials.gov study NCT03531827. IPD Sharing: YES. Countries: 1. Publications: 3.
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT02129556. IPD Sharing: Not stated. Countries: 5. Publications: 5.
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT01308580. IPD Sharing: Not stated. Countries: 22. Publications: 5.
Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01498978. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases
ClinicalTrials.gov study NCT02135484. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide
ClinicalTrials.gov study NCT02312557. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02788773. IPD Sharing: NO. Countries: 1. Publications: 1.
Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT01196741. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02272790. IPD Sharing: YES. Countries: 3. Publications: 1.
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT01308567. IPD Sharing: Not stated. Countries: 25. Publications: 6.
A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01717898. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
ClinicalTrials.gov study NCT03834493. IPD Sharing: YES. Countries: 28. Publications: 2.
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03148795. IPD Sharing: YES. Countries: 14. Publications: 2.
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT01807065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
ClinicalTrials.gov study NCT02854436. IPD Sharing: Not stated. Countries: 15. Publications: 2.
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhi
ClinicalTrials.gov study NCT03016312. IPD Sharing: Not stated. Countries: 21. Publications: 1.
Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00509366. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT03204812. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.